Publications

Latest publication 07/03/2014

Heme Oxygenase-1 Drives Metaflammation and Insulin Resistance in Mouse and Man

Obesity and diabetes affect more than half a billion individuals worldwide. Interestingly, the two conditions do not always coincide and the...

Array
(
    [id_prestablog_news] => 643
    [id_shop] => 1
    [date] => 2014-07-03 00:00:00
    [date_modification] => 2024-02-09 14:15:11
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [prim_key] => 1257
    [id_lang] => 1
    [title] => Heme Oxygenase-1 Drives Metaflammation and Insulin Resistance in Mouse and Man
    [paragraph] => Heme Oxygenase-1 Drives Metaflammation and Insulin Resistance in Mouse and Man
    [content] => 
Authors
Alexander Jais,Elisa Einwallner, Omar Sharif, Klaus Gossens et al.

 Lab
Medical University of Vienna, Vienna, Austria
Journal
Cell
Abstract
Obesity and diabetes affect more than half a billion individuals worldwide. Interestingly, the two conditions do not always coincide and the molecular determinants of “healthy” versus “unhealthy” obesity remain ill-defined. Chronic metabolic inflammation (metaflammation) is believed to be pivotal. Here, we tested a hypothesized anti-inflammatory role for heme oxygenase-1 (HO-1) in the development of metabolic disease. Surprisingly, in matched biopsies from “healthy” versus insulin-resistant obese subjects we find HO-1 to be among the strongest positive predictors of metabolic disease in humans. We find that hepatocyte and macrophage conditional HO-1 deletion in mice evokes resistance to diet-induced insulin resistance and inflammation, dramatically reducing secondary disease such as steatosis and liver toxicity. Intriguingly, cellular assays show that HO-1 defines prestimulation thresholds for inflammatory skewing and NF-?B amplification in macrophages and for insulin signaling in hepatocytes. These findings identify HO-1 inhibition as a potential therapeutic strategy for metabolic disease.
BIOSEB Instruments Used
OXYLET, Indirect Calorimeter (OXYLET)
    [meta_description] => 
    [meta_keywords] => http://www.sciencedirect.com/science/article/pii/S0092867414006710
    [meta_title] => 
    [link_rewrite] => heme-oxygenase-1-drives-metaflammation-and-insulin-resistance-in-mouse-and-man
    [actif_langue] => 1
    [read] => 1035
    [count_comments] => 0
    [id] => 643
    [categories] => Array
        (
            [26] => Array
                (
                    [id_prestablog_categorie] => 26
                    [title] => Miscellaneous research domains
                    [link_rewrite] => Miscellaneous-research-domains
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => Heme Oxygenase-1 Drives Metaflammation and Insulin Resistance in Mouse and Man
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [25] => Array
                (
                    [name] => OXYLET- Indirect Calorimeter
                    [description_short] => 
The OXYLET system - Physiocage is a modular system allowing the integration
 of respiratory metabolism (O2 consumption / CO2 production),
 food & drink intake, activity and rearing measurements
 in specifically adapted home cages in rodents.
                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/bioseb2024/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://bioseb.com/en/metabolism-nutrition/25-oxylet-indirect-calorimeter.html
                )

        )

)
1